Multinational corporations bemoaned their underdog status and Doug Long made a Yogi Berra joke. If it hadn’t been for the hotel staff in masks and the six-piece “protection kit” at every chair, the Association for Accessible Medicines’ annual meeting in Orlando earlier this year might have seemed unchanged, despite the two-year break from the gathering imposed by COVID.
Back To Normal-ish: What To Expect As Pharma Resumes In-Person Gatherings
With the mask mandate now lifted for air travel and the grimmer milestone of one million Americans dead from COVID approaching, the Pink Sheet looks back at the generic trade association’s annual meeting to see what business gatherings may look like going forward.
More from Generics
• By
Amid ongoing generic drug supply problems, Japan's government is to set up a new fund to support corporate investments geared towards manufacturing and consolidation.
• By
Optum Rx, one of the largest PBMs in the US, declared it was the “first comprehensive, transparent pharmacy services company” after announcing several consumer-friendly changes.
• By
Teva was forced to delist its ProAir HFA inhaler patents from the FDA’s Orange Book by mid-March after the Federal Circuit denied its petition for en banc rehearing. Will the Supreme Court listen?
• By
Multiple sources, including former Acting FDA Commissioner Janet Woodcock, told the Pink Sheet that industry is quietly complaining about FDA work delays and they expect the problem will worsen.